Rights and permissions
About this article
Cite this article
Novartis wins against GSK, `Toprol' faces generic challenge. Pharmacoecon. Outcomes News 408, 11 (2003). https://doi.org/10.1007/BF03276137
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276137